Dianthus Therapeutics | MGTA - Ativos





Ativos Alterar Data
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Avita Medical AUD 56.39M 1.74M 2025-12
Celltrion KRW 768.81B 9.37B 2026-03
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Moderna USD 11.49B 850M 2026-03
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 521.31M 9.36M 2026-03
Organon & Co USD 13B 129M 2026-03
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pharma Mar EUR 385.26M 9.82M 2026-03
Qiagen NV USD 6.3B 257.54M 2025-12
Revvity USD 12B 171.82M 2026-03
Sartorius EUR 9.87B 154.9M 2026-03
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Tilray USD 2.1B 15.95M 2025-09
Viatris USD 36.83B 358.5M 2026-03
Xeris Pharmaceuticals USD 392.01M 8.49M 2026-03
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03